PubMed Health⌕ Search

PubMed · 9258158

Enteric mucosal regrowth after bladder augmentation using demucosalized gut segments.

Abstract

PURPOSE: Regrowth of the enteric mucosa on a denuded muscular flap enterocystoplasty is an undesirable complication of demucosalized enterocystoplasty. This study was performed to understand how regrowth can be prevented and, thus, a complete urothelial lined enterocystoplasty can be achieved. MATERIALS AND METHODS: We performed bladder augmentation on 30 sheep using demucosalized seromuscular gastric or colonic flaps with or without autoaugmentation. The epithelium and muscularis mucosae were completely removed from the gastric flap. Initial attempts to remove the muscularis mucosae and most of the submucosal layer from the colonic flap by cautery caused bleeding and muscle damage. Thus, demuscosalization was done by stripping with forceps, in which the muscularis mucosae and submucosa remained largely intact on the colonic flap. Sheep were sacrificed 4 to 12 months postoperatively and bladders were inspected for mucosal regrowth. Subsequently autoaugmentation with demucosalized seromuscular gastric or colonic flaps was performed clinically in 10 children in whom the enteric epithelium and muscularis mucosae were removed completely with part of the submucosa by dissection through the submucosal plane. These children were followed with urodynamic studies and mucin staining of urine up to 39 months postoperatively. RESULTS: Regrowth of islands of enteric mucosa occurred in 4 of the 5 animals in which the muscularis mucosae and submucosal layers were preserved on a colonic flap. In all animals with mucosal regrowth the bowel was prepared by stripping the mucosa. Mucosal regrowth did not occur in any animal after complete removal of the muscularis mucosae and the inner portion of the submucosa from the stomach or colon. All patients had satisfactory urodynamic results and no evidence of enteric mucosal regrowth. CONCLUSIONS: Removal of the muscularis mucosae with the inner portion of the submucosa appears necessary to prevent enteric mucosal regrowth on the muscular flap of a demucosalized enterocystoplasty. In addition, this level of dissection does not seem to interfere with the success of bladder augmentation in children.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

P A Dewan, C E Close, R W Byard, P J Ashwood, M E Mitchell. 1997. Enteric mucosal regrowth after bladder augmentation using demucosalized gut segments.. https://doi.org/10.1097/00005392-199709000-00114

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Protocol for Detecting and Sequencing Chikungunya Virus from Field-Collected Mosquitoes.

Arboviral diseases represent a major public health challenge, especially in tropical regions where environmental conditions may favor the proliferation and spread of mosquito vectors. Thus, early and accurate detection of chikungunya virus (CHIKV) in mosquito populations can be a valuable tool for effective surveillance of circulating variants and for identifying new viral introductions. Given the challenges of detecting arboviruses in field-captured mosquitoes, we describe an integrated workflow for CHIKV molecular detection and whole-genome sequencing. This protocol includes mosquito homogenization using a bead-based mechanical disruptor, RNA extraction using TRIzol reagent with minor modifications, molecular screening using CHIKV-specific RT-qPCR, and whole-genome amplification followed by sequencing on Illumina platforms. Despite the protocol being optimized for individual mosquitoes, it results in high-quality RNA suitable for both entomological surveillance and genomic analysis. As this protocol allows recovery of complete CHIKV genomes from mosquito specimens, it can serve as a basis for genomic epidemiology studies, enabling monitoring of viral diversity and lineage dynamics, and facilitating early detection of emerging variants to support timely and targeted public health interventions in endemic and at-risk regions.

Animals↗

Genomic Profiling of Chromatin State Using CUT&Tag.

Alterations in chromatin state, mediated through histone modifications and the incorporation of histone variants, are fundamental to establishing transcriptional networks and cell identity. Recent advances in low-input epigenome profiling methods, such as CUT&Tag and CUT&RUN, have enabled the study of chromatin states from very limited starting materials. In this chapter, we describe procedures for generating CUT&Tag libraries to profile histone modifications and histone variants in early-developing zebrafish embryos.

Animals↗

Relaxin-2: Shaping the Proteomic Landscape of Skeletal Muscle Physiology, Glucose Trafficking, and Mitochondrial Function in Rat.

Relaxin-2 is a hormone with robust beneficial effects on the heart and blood vessels and potential as a therapy for cardiovascular (CV) disease. Considering the interorgan communication between skeletal muscle and heart, and the relation between muscle quality/composition and CV events, we hypothesize that relaxin-2 may regulate skeletal muscle physiology and metabolism. We aim to evaluate the impact of relaxin-2 on the proteome of skeletal muscle from healthy Sprague-Dawley rats. Animals were treated with 0.4 mg/kg/day of serelaxin (recombinant form of human relaxin-2) or vehicle (PBS) for 2 weeks employing subcutaneous osmotic minipumps. Skeletal muscle protein identification and quantification were performed by LC-MS/MS using a Data-Independent Acquisition (DIA)-Sequential Window Acquisition of All Theoretical Fragment Ion Spectra (SWATH) method. SWATH/MS quantitative analysis identified that relaxin-2 significantly decreased 95 proteins and significantly increased 32 proteins in rat skeletal muscle when compared to control rats. From these, 34 proteins were associated with muscle function, myogenesis, muscle differentiation and/or regeneration, 20 are mitochondrial proteins (six from the complexes of the electron transport chain), and 10 proteins participate in glucose metabolism. Qualitative data-dependent workflow analysis identified 35 proteins exclusive to the skeletal muscle of the relaxin-2-treated group: eight proteins related to processes of skeletal muscle function (size, ion homeostasis or organization of caveolae structures and cytoskeleton) and myogenesis, and two proteins involved in muscle differentiation. Our work highlighted for the first time the role of relaxin-2 in crucial processes of muscle physiology and energetic metabolism, which could influence several processes involved in myopathy and CV.

Animals↗